The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
as the atherosclerotic diseases um along with the fourth Horsemen which is the metabolic diseases are probably the two that we have the most insight into um as far as what are the pathophysiologic drivers and therefore we either theoretically uh or in some cases practically also have I think the best insight into how to prevent them
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.